Authors: MULLIGAN T CARRASQUILLO JA CHUNG Y MILENIC DE SCHLOM J FEUERSTEIN I PAIK C PERENTESIS P REYNOLDS J CURT G GOECKELER W FORDYCE W CHENG R RISEBERG D COWAN K OSHAUGHNESSY J

Citation: T. Mulligan et al., PHASE-I STUDY OF INTRAVENOUS LU-177-LABELED CC49 MURINE MONOCLONAL-ANTIBODY IN PATIENTS WITH ADVANCED ADENOCARCINOMA, Clinical cancer research, 1(12), 1995, pp. 1447-1454

Authors: CARRASQUILLO J MULLIGAN T CHUNG Y MILENIC D LORA M SCHLOM J GOECKELER W FORDYCE W CHENG R FEUERESTEIN I PERENTESIS P PALK CH CURT G COWAN K OSHAUGHNESSY J

Citation: J. Carrasquillo et al., PHARMACOKINETICS AND BIODISTRIBUTION OF INTRAVENOUS LU-177 CC49 MURINE MONOCLONAL-ANTIBODY (MAB) IN PATIENTS WITH METASTATIC ADENOCARCINOMA, The Journal of nuclear medicine, 35(5), 1994, pp. 160000100-160000101

Authors: SCHOTT ME SCHLOM J SILER K MILENIC DE EGGENSPERGER D COLCHER D CHENG R KRUPER WJ FORDYCE W GOECKELER W

Citation: Me. Schott et al., BIODISTRIBUTION AND PRECLINICAL RADIOIMMUNOTHERAPY STUDIES USING RADIOLANTHANIDE-LABELED IMMUNOCONJUGATES, Cancer, 73(3), 1994, pp. 993-998